From: COVID-19 pandemic: CT chest in COVID-19 infection and prediction of patient’s ICU needs
Variables | Total (N = 466) | Positive (N = 340) | Negative (N = 126) | P value | |
---|---|---|---|---|---|
Mean age (years) | 46.0 ± 14.8 | 38.2 ± 21.2 | 44.0 ± 17.1 | ^< 0.001 * | |
Sex | Male | 295 (63.3%) | 212 (62.4%) | 83 (65.9%) | # 0.484 |
Female | 171 (36.7%) | 128 (37.6%) | 43 (34.1%) | ||
CT probability | High | 240 (51.5%) | 237 (69.7%) | 3 (2.4%) | # < 0.001* |
Intermediate | 52 (11.2%) | 41 (12.1%) | 11 (8.7%) | ||
Low | 64 (13.7%) | 37 (10.9%) | 27 (21.4%) | ||
Negative | 110 (23.6%) | 25 (7.4%) | 85 (67.5%) | ||
GGO (ground-glass opacity) | 306 (65.7%) | 292 (85.9%) | 14 (11.1%) | # < 0.001* | |
GGO rounded | 169 (55.2%) | 162 (55.5%) | 7 (50.0%) | # 0.687 | |
GGO linear | 68 (22.2%) | 65 (22.3%) | 3 (21.4%) | § 1.000 | |
GGO patchy | 52 (17.0%) | 49 (16.8%) | 3 (21.4%) | § 0.714 | |
GGO confluence | 39 (12.7%) | 39 (13.4%) | 0 (0.0%) | § 0.229 | |
GGO diffuse | 4 (1.3%) | 3 (1.0%) | 1 (7.1%) | § 0.172 | |
GGO laterality | Unilateral | 37 (12.1%) | 35 (12.0%) | 2 (14.3%) | # 0.681 |
Bilateral | 269 (87.9%) | 257 (88.0%) | 12 (85.7%) | ||
GGO location | Peripheral | 275 (89.9%) | 271 (92.8%) | 4 (28.6%) | # < 0.001* |
Central | 31 (10.1%) | 21 (7.2%) | 10 (71.4%) | ||
GGO lobar affection | Multilobar | 285 (93.1%) | 271 (92.8%) | 14 (100.0) | # 0.609 |
Unilobar | 21 (6.9%) | 21 (7.2%) | 0 (0.0%) | ||
Crazy paving | 162 (34.8%) | 154 (45.3%) | 8 (6.3%) | # < 0.001* | |
Vascular enlargement | 104 (22.3%) | 100 (29.4%) | 4 (3.2%) | # < 0.001* | |
Consolidation | 128 (27.5%) | 98 (28.8%) | 30 (23.8%) | # 0.281 | |
Consolidation type | Lobar | 42 (32.8%) | 25 (25.5%) | 17 (56.7%) | # 0.001 * |
Segmental/subsegmental | 86 (67.2%) | 73 (74.5%) | 13 (43.3%) | ||
Consolidation > GG | 77 (16.5%) | 52 (15.3%) | 25 (19.8%) | # 0.240 | |
Curvilinear opacity | 94 (20.2%) | 90 (26.5%) | 4 (3.2%) | # < 0.001* | |
Pleural effusion | 62 (13.3%) | 38 (11.2%) | 24 (19.0%) | # 0.026 * | |
Fibrosis | 22 (4.7%) | 17 (5.0%) | 5 (4.0%) | 0.641 | |
LN (lymphadenopathy) | 17 (3.6%) | 11 (3.2%) | 6 (4.8%) | § 0.415 | |
Nodules | 23 (4.9%) | 11 (3.2%) | 12 (9.5%) | # 0.005 * | |
Bronchiectasis | 10 (2.1%) | 8 (2.4%) | 2 (1.6%) | § 1.000 | |
Cavitation | 6 (1.3%) | 1 (0.3%) | 5 (4.0%) | § 0.006 * |